Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.

Rush CR, Baker RW.

Exp Clin Psychopharmacol. 2001 Feb;9(1):59-73.

PMID:
11519636
[PubMed - indexed for MEDLINE]
2.

Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.

Stoops WW, Lile JA, Glaser PE, Rush CR.

Exp Clin Psychopharmacol. 2005 Feb;13(1):56-64.

PMID:
15727504
[PubMed - indexed for MEDLINE]
3.

Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.

Rush CR, Kollins SH, Pazzaglia PJ.

Exp Clin Psychopharmacol. 1998 Feb;6(1):32-44.

PMID:
9526144
[PubMed - indexed for MEDLINE]
4.

Discriminative-stimulus effects of modafinil in cocaine-trained humans.

Rush CR, Kelly TH, Hays LR, Wooten AF.

Drug Alcohol Depend. 2002 Aug 1;67(3):311-22.

PMID:
12127202
[PubMed - indexed for MEDLINE]
5.

Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.

Rush CR, Baker RW, Rowlett JK.

Exp Clin Psychopharmacol. 2000 Feb;8(1):22-36.

PMID:
10743902
[PubMed - indexed for MEDLINE]
6.

Behavioral and physiological effects of cocaine in humans following triazolam.

Haga JL, Baker RW, Rush CR.

Pharmacol Biochem Behav. 2003 Dec;76(3-4):383-92.

PMID:
14643836
[PubMed - indexed for MEDLINE]
7.

Acute behavioral and physiological effects of modafinil in drug abusers.

Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF.

Behav Pharmacol. 2002 Mar;13(2):105-15.

PMID:
11981223
[PubMed - indexed for MEDLINE]
8.

Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.

Lile JA, Stoops WW, Wagner FP, Glaser PE, Rush CR.

Pharmacol Biochem Behav. 2005 Oct;82(2):270-9. Epub 2005 Sep 22.

PMID:
16182353
[PubMed - indexed for MEDLINE]
9.

Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.

Sevak RJ, Stoops WW, Hays LR, Rush CR.

J Pharmacol Exp Ther. 2009 Mar;328(3):1007-18. doi: 10.1124/jpet.108.147124. Epub 2008 Dec 22.

PMID:
19104030
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.

Lile JA, Stoops WW, Durell TM, Glaser PE, Rush CR.

Exp Clin Psychopharmacol. 2006 May;14(2):136-47.

PMID:
16756417
[PubMed - indexed for MEDLINE]
11.

Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.

Stoops WW, Glaser PE, Fillmore MT, Rush CR.

J Psychopharmacol. 2004 Dec;18(4):534-43.

PMID:
15582920
[PubMed - indexed for MEDLINE]
12.

Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.

Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK.

J Pharmacol Exp Ther. 1997 Jan;280(1):174-88.

PMID:
8996195
[PubMed - indexed for MEDLINE]
Free Article
13.

Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis.

Rush CR, Baker RW, Wright K.

Drug Alcohol Depend. 1999 Jun 1;55(1-2):1-12.

PMID:
10402144
[PubMed - indexed for MEDLINE]
14.

Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.

Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Badger G.

Behav Pharmacol. 1997 Jun;8(2-3):124-38.

PMID:
9833008
[PubMed - indexed for MEDLINE]
15.

Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.

Kollins SH, Rush CR, Pazzaglia PJ, Ali JA.

Exp Clin Psychopharmacol. 1998 Nov;6(4):367-74.

PMID:
9861551
[PubMed - indexed for MEDLINE]
16.

Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment.

Roache JD, Grabowski J, Schmitz JM, Creson DL, Rhoades HM.

J Clin Psychopharmacol. 2000 Feb;20(1):61-8.

PMID:
10653210
[PubMed - indexed for MEDLINE]
17.

Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.

Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR.

Behav Pharmacol. 1998 May;9(3):207-17.

PMID:
9832935
[PubMed - indexed for MEDLINE]
18.

Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis.

Stoops WW, Glaser PE, Rush CR.

Drug Alcohol Depend. 2003 Aug 20;71(2):179-86.

PMID:
12927656
[PubMed - indexed for MEDLINE]
19.

Secobarbital in humans discriminating triazolam under two-response and novel-response procedures.

Kamien JB, Bickel WK, Smith BJ, Badger GJ, Hughes JR.

Pharmacol Biochem Behav. 1997 Dec;58(4):983-91.

PMID:
9408204
[PubMed - indexed for MEDLINE]
20.

Low-dose oral cocaine in humans: acquisition of discrimination and time-course of effects.

Epstein DH, Silverman K, Henningfield JE, Preston KL.

Behav Pharmacol. 1999 Sep;10(5):531-42.

PMID:
10780259
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk